A repost of the FDA decision clearing Lilly's tirzepatide shot Zepbound to treat obstructive sleep apnea, a story that broke earlier.
Recap by typeshit. Full story at www.polskieradio.pl.
The MFDS approval rests on SURPASS-CVOT, where Mounjaro matched Trulicity on heart events in 13,000+ patients but did not prove superior.
Inside Retail Asia looks at skincare and aesthetic treatments brands are building for facial volume loss after rapid weight loss.
The actor told an interviewer people can take Ozempic carefree, while stressing that nothing replaces actually working out.
CFO MV Narasimham says the company still expects to ship 6 to 7 million pens across 10 approved markets between November and March, with Canada taking most of them.
12:10
InforMed breaks down the head-to-head question between Novo's CagriSema and tirzepatide using the 84-week trial results.
15:25
Doctor Alex says Ozempic works but comes with a catch, and walks through what he thinks people misunderstand about GLP-1 drugs.
Loading…